Correlation Between Quoin Pharmaceuticals and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Regen BioPharma, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Regen BioPharma.
Diversification Opportunities for Quoin Pharmaceuticals and Regen BioPharma
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Quoin and Regen is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Regen BioPharma go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and Regen BioPharma
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Regen BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Quoin Pharmaceuticals Ltd is 2.81 times less risky than Regen BioPharma. The stock trades about -0.14 of its potential returns per unit of risk. The Regen BioPharma is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 15.00 in Regen BioPharma on November 2, 2024 and sell it today you would lose (8.79) from holding Regen BioPharma or give up 58.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. Regen BioPharma
Performance |
| Timeline |
| Quoin Pharmaceuticals |
| Regen BioPharma |
Quoin Pharmaceuticals and Regen BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quoin Pharmaceuticals and Regen BioPharma
The main advantage of trading using opposite Quoin Pharmaceuticals and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Allarity Therapeutics | Quoin Pharmaceuticals vs. Biodexa Pharmaceticals |
| Regen BioPharma vs. Creative Medical Technology | Regen BioPharma vs. Therasense | Regen BioPharma vs. Enzolytics | Regen BioPharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |